Snakebite Antivenom is Running Out
New stocks to expire by next year.

Goran Tomasevic/Reuters
Get the Beast Digest newsletter delivered straight to your inbox
By clicking “SIGN UP” you agree to our Terms of Use and Privacy Policy.
Officials warned Monday that the world is running out one of the most effective snakebite antivenoms. Stocks of Fav-Afrique, which can treat 10 different snakebites that can occur in Sub-Saharan Africa, are dangerously low and will run out by next year, according to Medicins Sans Frontieres (MSF). Alternate treatments are available but aren’t as effective, the group said. Manufacturer Sanofi Pasteur said the antivenom has been priced out of the market, but it plans to share the serum’s recipe with other companies. MSF warned that a replacement product could not be expected to be on the market for an additional two years, which could put tens of thousands of lives at risk. An estimated five million people around the world are bitten by snakes each year, the World Health Organization said.
Unlock a year of full access to The Daily Beast for $35.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Looks like you already have a subscription!
- Account (completed)
- Payment (completed)
- Confirmation (completed)
You're all set!
Thanks for subscribing.
- 1Account
- 2Payment
- 3Confirmation
Sign in or create an account
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
- Account (completed)
- Payment (completed)
- Confirmation (completed)
You're all set!
Thanks for subscribing.
- 1Account
- 2Payment
- 3Confirmation